Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct.

An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Ola Engkvist is the Executive Director and Head of Molecular AI in Discovery Sciences within R&D at AstraZeneca (headquartered in Cambridge, UK). His team harnesses advanced computational technologies ...

Using 3-D Modeling to Optimize Small Molecule Drug Discovery Structure-based drug designers identify and optimize small molecules that affect the activity of target proteins, such as kinases, by ...

Although COVID-19 has faded from the headlines, SARS-CoV-2 – the coronavirus behind the pandemic – is still rampantly infecting people around the world. Public health officials fear as the virus ...